Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS)

CUSIP: 03615A108

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
19,607,843
Total 13F shares
834,363
Share change
+73,452
Total reported value
$23,108,000
Price per share
$27.90
Number of holders
29
Value change
+$2,874,108
Number of buys
19
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 03615A108?
CUSIP 03615A108 identifies ANVS - Annovis Bio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ANVS - Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AIGH Capital Management LLC
13F
Company
2.4%
463,797
$3,497,000 31 Dec 2020
13F
Worth Venture Partners, LLC
13F
Company
0.61%
119,538
$901,000 31 Dec 2020
13F
Sterling Investment Advisors, Ltd.
13F
Company
0.26%
50,588
$381,000 31 Dec 2020
13F
Modera Wealth Management, LLC
13F
Company
0.22%
43,846
$331,000 31 Dec 2020
13F
Lokken Investment Group LLC
13F
Company
0.16%
32,211
$243,000 31 Dec 2020
13F
BROWN ADVISORY INC
13F
Company
0.08%
14,942
$113,000 31 Dec 2020
13F
MORGAN STANLEY
13F
Company
0.07%
14,286
$108,000 31 Dec 2020
13F
Cannell & Co.
13F
Company
0.05%
10,000
$75,000 31 Dec 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0.04%
7,396
$56,000 31 Dec 2020
13F
Sowell Financial Services LLC
13F
Company
0.01%
1,529
$12,000 31 Dec 2020
13F
Rockefeller Capital Management L.P.
13F
Company
0.01%
1,000
$7,000 31 Dec 2020
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
778
$6,000 31 Dec 2020
13F

Institutional Holders of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) as of Q1 2021

As of 31 Mar 2021, Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 834,363 shares. The largest 10 holders included Ikarian Capital, LLC, VANGUARD GROUP INC, AIGH Capital Management LLC, EAM Investors, LLC, Modera Wealth Management, LLC, Sterling Investment Advisors, Ltd., Worth Venture Partners, LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and BOOTHBAY FUND MANAGEMENT, LLC. This page lists 29 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
12
Q1 2021 holders
29
Holder diff
17
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 Value $ Q1 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.